Background: A major barrier to a healthy diet may be the higher price of healthy foods compared to low-quality foods.
Objectives: This study aimed to assess the association between the monetary cost of food and diet quality in Spanish older adults at high risk of cardiovascular disease.
Methods: Cross-sectional analysis was carried out in Spanish older adults ( = 6,838; 48.
Background: Metabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet.
Aims: To assess the association between MetS severity and amount of carbon dioxide (CO) emitted in an adult population.
Aims: To assess the comparative effects of glucagon-like peptide-1 receptor agonists (GLP-1RA), 4-dipeptidyl peptidase inhibitors (DPP-4I), and metformin treatment during one year on metabolic syndrome (MetS) components and severity in MetS patients.
Methods: Prospective study (n = 6165 adults) within the frame of PREDIMED-Plus trial. The major end-point was changes on MetS components and severity after one- year treatment of GLP-1RA, DPP-4I, and metformin.
Background: Research related to sustainable diets is is highly relevant to provide better understanding of the impact of dietary intake on the health and the environment.
Aim: To assess the association between the adherence to an energy-restricted Mediterranean diet and the amount of CO emitted in an older adult population.
Design And Population: Using a cross-sectional design, the association between the adherence to an energy-reduced Mediterranean Diet (erMedDiet) score and dietary CO emissions in 6646 participants was assessed.
Background: Metabolic syndrome (MetS) worsens quality of life and increases mortality. Dissatisfaction with weight in patients with MetS may modify the effect of lifestyle interventions to achieve changes in health-related behaviors.
Objective: To assess 1-year changes in cardiovascular risk scores, self-perceived general health and health-related behaviors according to observed changes in desired weight loss during the first year of intervention in a large cardiovascular prevention trial.